FORWARD PHYSIO
ActiveSummary
FORWARD PHYSIO has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €25,604 and a net result of €7,933. Equity has been growing by about 42% per year since 2022. Its solvency ranks better than 23% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
Overview
Official details
Source: KBO- Status
- Active since 18-03-2022 Normal situation
- Activity
- Physiotherapy NACE 86951and 2 others
- Establishment unit
- 2.329.062.545 8800 Roeselare, since 18-03-2022
- Financial year end
- 31 December
- Peppol
- Reachable since 19-11-2025
Financial position
- Bankruptcy probabilitywithin 12 months
- < 0.1%
Annual accounts 2025
- Gross margin
- €26,406
- ▼ 50.6%
- Turnover
- ≈ €80,000
- estimated
- Profit
- €7,933
- ▼ 81.6%
- Equity
- €25,604
- ▼ 46.3%
- Total assets
- €103,281
- ▲ 23.2%
Filed on 22-06-2026, 39 days before the deadline
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 0.72, cash €21,503, halvedSize: total assets €103,281Figures for financial year 2025 (filed on 22-06-2026)Show the evidence
Checked score
Score 2025
90
/ 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 21% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency
50-32
equity 24.8% of total assets
Liquidity
51-28
short-term debt 50.0% · cash 20.8%
Profitability
78-22
return on assets 7.7%
Bankruptcy probability within 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: < 0.1%
01-2025: < 0.1%● unchanged vs 12-2024
02-2025: < 0.1%● unchanged vs 01-2025
03-2025: < 0.1%● unchanged vs 02-2025
04-2025: < 0.1%● unchanged vs 03-2025
05-2025: < 0.1%● unchanged vs 04-2025
06-2025: < 0.1%● unchanged vs 05-2025
07-2025: < 0.1%● unchanged vs 06-2025
08-2025: < 0.1%● unchanged vs 07-2025
09-2025: < 0.1%● unchanged vs 08-2025
10-2025: < 0.1%● unchanged vs 09-2025
11-2025: < 0.1%● unchanged vs 10-2025
12-2025: < 0.1%● unchanged vs 11-2025
01-2026: < 0.1%● unchanged vs 12-2025lowest value
02-2026: < 0.1%● unchanged vs 01-2026lowest value
03-2026: < 0.1%● unchanged vs 02-2026
04-2026: < 0.1%● unchanged vs 03-2026
05-2026: < 0.1%● unchanged vs 04-2026
06-2026: < 0.1%● unchanged vs 05-2026
07-2026: < 0.1%● unchanged vs 06-2026
08-2026: < 0.1%● unchanged vs 07-2026
09-2026: < 0.1%● unchanged vs 08-2026
10-2026: < 0.1%● unchanged vs 09-2026highest value
11-2026: < 0.1%● unchanged vs 10-2026highest value
Credit of up to €2,000 on 30-day terms is acceptable
Liquidity is insufficient, with a current ratio of 0.72 (2.29 in 2024), below 1. Short-term debt is 50% and cash 20.8% of total assets. 75.2% of the assets are financed with debt and provisions.
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 23% of them on solvency, 24% on liquidity, 23% on profitability and 13% on growth.
The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Six signals.
lowers riskraises riskneutral
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 23% of 20678 sector peers (2025).
NBB · sector comparisonPosition among 20678 sector peers
Solvency
better than 23%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 22-06-2026, 39 days ahead of the deadline.
NBB · 4 filingsDeviation from the deadline
2025
39 days early
2024
36 days early
2023
16 days early
2022
14 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 4 accounts on average 26 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 6 July (4 of the last 4 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
Financials
Financials · financial year 2025, micro format
Annual accounts 2025 filed on 22-06-2026 at the NBB all 4 filings
Turnover
≈ €80,000
Estimated: probably between €61,000 and €110,000
Total assets
€103,281▲ 23.2%
2024 · €83,831
Net result
€7,933▼ 81.6%
2024 · €43,060
Working capital
-€14,489
2024 · €46,658
Trend over the years
2022 to 2025, 4 financial years
The operating result for 2025 is 78% lower than in 2024 and the lowest since 2022.
Operating result€10,964
2025
Net result€7,933
2025
Total assets€103,281
2025
Equity€25,604
2025
Debt€77,678
2025
Working capital-€14,489
2025
Return on assets (ROA)7.7%
2025
Solvency24.8%
2025
Current ratio0.72
2025
Turnover is what the company sold, the result is what was left of it. A loss stands below the zero line.
Assets, equity and debt per financial year.
Above zero, the company can pay its short-term debts with what it holds in the short term.
The EBIT margin is the share of each euro of turnover left from operations. The return on assets is what the assets earn.
The higher the solvency, the better the company absorbs a setback.
A ratio above 1 means the short-term assets cover the short-term debts.
Use the arrow keys on the chart for the figures per year.
The sector band is the middle half of the companies in Human health activities (NACE 86). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30. The dashed line is the median. There is a sector band for net result, equity, total assets, working capital, solvency, current ratio and return on assets (ROA).
Every figure with its change against the financial year before
favourable
unfavourable
Line2022202320242025
Operating result€29,151-€34,854▲ 19.6%€50,804▲ 45.8%€10,964▼ 78.4%
Net result€22,428below the sector's middle half-€28,405below the sector's middle half▲ 26.7%€43,060within the sector's middle half▲ 51.6%€7,933below the sector's middle half▼ 81.6%
Equity€15,248below the sector's middle half-€27,969below the sector's middle half▲ 83.4%€47,670within the sector's middle half▲ 70.4%€25,604below the sector's middle half▼ 46.3%
Total assets€37,096below the sector's middle half-€53,051below the sector's middle half▲ 43.0%€83,831below the sector's middle half▲ 58.0%€103,281below the sector's middle half▲ 23.2%
Debt€21,849-€25,082▲ 14.8%€36,161▲ 44.2%€77,678▲ 115%
Working capital€12,443below the sector's middle half-€26,061below the sector's middle half▲ 109%€46,658within the sector's middle half▲ 79.0%-€14,489below the sector's middle half
Solvency41.1%within the sector's middle half-52.7%within the sector's middle half▲ 11.6pp56.9%within the sector's middle half▲ 4.1pp24.8%below the sector's middle half▼ 32.1pp
Current ratio1.57within the sector's middle half-2.04within the sector's middle half▲ 0.472.29within the sector's middle half▲ 0.250.72below the sector's middle half▼ 1.57
Return on assets (ROA)60.5%above the sector's middle half-53.5%above the sector's middle half▼ 6.9pp51.4%above the sector's middle half▼ 2.2pp7.7%below the sector's middle half▼ 43.7pp
above
within
below
The sector band is the middle half of the companies in Human health activities (NACE 86). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin are not published. The abbreviated or micro format does not require them. The turnover shown is an estimate from the gross margin.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €103,281
Fixed assets
€66,141 ▲ 65×
Current assets
€37,141 ▼ 55.2%
Equity and liabilities €103,281
Equity
€25,604 ▼ 46.3%
Debt
€77,678 ▲ 115%
Debt's share of the balance-sheet total rises from 43.1% to 75.2%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€23,782▼
2024 · €51,700
Cash flow
€20,752▼
2024 · €43,956
Debt to equity
3.03▲
2024 · 0.76
ROE
31.0%▼
2024 · 90.3%
Interest coverage
14.26▼
2024 · 30.35
Debt ≤ 1 year
€51,630▲
2024 · €36,161
Debt > 1 year
€26,048
Income taxes
€1,363▼
2024 · €6,041
Green means a favourable move, even when the figure itself falls, as with debt or debt to equity.
Investments
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Tangible fixed assets | €3,283 | - | - | €75,547 |
| Financial fixed assets | - | - | - | €2,400 |
| Depreciation and write-downs of the year | €3,247 | €896 | €896 | €12,818 |
Source: notes to the 2022 to 2025 annual accounts (statement of fixed assets)
Subsidies and aid
Flemish government
2022 to 2025 · 4 entries · €3,512 awarded · €3,755 paid| Year | Entries | Awarded | Paid |
|---|---|---|---|
| 2025 | 1 | €1,446 | €1,446 |
| 2024 | 1 | €539 | €539 |
| 2023 | 1 | €851 | €1,094 |
| 2022 | 1 | €676 | €676 |
Comparable companies
These companies have the same main activity as FORWARD PHYSIO: physiotherapy (NACE 86951). They are comparable in size and age: total assets between €92,800 and €121,000, founded between 2021 and 2022.
| Company | Founded | Total assets | Equity | Gross margin | Net result | FTE | Financial year |
|---|---|---|---|---|---|---|---|
| FORWARD PHYSIO Roeselare | 2022 | €103,281 | €25,604 | €26,406 | €7,933 | - | 2025 |
| Florian Vanhevel Torhout | 2022 | €92,833 | €3,600 | €26,215 | €9,943 | - | 2025 |
| Fysio-S Roosdaal | 2022 | €97,091 | €91,856 | €26,104 | €18,315 | - | 2025 |
| Beg(h)in to recover Dilbeek | 2022 | €115,982 | €55,430 | €27,391 | €21,358 | 0 | 2025 |
| Improve Lievegem Lievegem | 2021 | €94,012 | €40,730 | €26,708 | €3,163 | - | 2025 |
| KINE DEROANNE Stavelot | 2022 | €120,826 | €41,082 | €26,410 | €12,366 | - | 2025 |
| KAD THERAPY Wemmel | 2022 | €100,298 | €93,300 | €30,069 | €19,000 | - | 2025 |
They were chosen from the 2,297 other active companies with that main activity and annual accounts from the past two years. All companies with this main activity
Companies with the same profile, two years later
Historical observationIn July 2024, 7,976 companies had the same profile as FORWARD PHYSIO has now. Two years later, 3.6% had gone bankrupt and 94.3% were still going.
- Micro
- 2 to 5 years old
- solvency 10 to 30%
- a profit of 5% of the balance sheet or more
3.6%
went bankrupt
1.8%
stopped otherwise
94.3%
was still going
Another 0.3% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of FORWARD PHYSIO itself is lower: < 0.1% within 12 months. It rests on far more data about FORWARD PHYSIO than the profile alone.
Test of the method
The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 7,976 companies, not a prediction for FORWARD PHYSIO. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Annual accounts
| Line | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €3,247 | €896 | €896 | €12,818 | ▲ 14× |
| Other operating charges640/8 | €1,580 | €1,416 | €1,783 | €2,623 | ▲ 47.1% |
| Gross operating margin9900 | €33,977 | €37,167 | €53,484 | €26,406 | ▼ 50.6% |
| Operating profit (loss)9901 | €29,151 | €34,854 | €50,804 | €10,964 | ▼ 78.4% |
| Financial charges65/66B | €223 | €525 | €1,703 | €1,668 | ▼ 2.1% |
| Recurring financial charges65 | €223 | €525 | €1,703 | €1,668 | ▼ 2.1% |
| Profit (loss) for the period before taxes9903 | €28,928 | €34,329 | €49,101 | €9,296 | ▼ 81.1% |
| Income taxes67/77 | €6,500 | €5,924 | €6,041 | €1,363 | ▼ 77.4% |
| Profit (loss) for the period9904 | €22,428 | €28,405 | €43,060 | €7,933 | ▼ 81.6% |
| Profit (loss) for the period to be appropriated9905 | €22,428 | €28,405 | €43,060 | €7,933 | ▼ 81.6% |
| Line | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|
| Assets | |||||
| Total assets20/58 | €37,096 | €53,051 | €83,831 | €103,281 | ▲ 23.2% |
| Fixed assets21/28 | €2,805 | €1,908 | €1,012 | €66,141 | ▲ 65× |
| Tangible fixed assets22/27 | €2,805 | €1,908 | €1,012 | €63,741 | ▲ 63× |
| Plant, machinery and equipment23 | €1,344 | €745 | €146 | €43,000 | ▲ 294× |
| Furniture and vehicles24 | €1,461 | €1,164 | €866 | €3,545 | ▲ 309% |
| Other tangible fixed assets26 | - | - | - | €17,195 | - |
| Financial fixed assets28 | - | - | - | €2,400 | - |
| Current assets29/58 | €34,292 | €51,143 | €82,819 | €37,141 | ▼ 55.2% |
| Amounts receivable within one year40/41 | €3,700 | €5,250 | €11,209 | €9,637 | ▼ 14.0% |
| Trade receivables40 | €3,700 | - | - | - | - |
| Other amounts receivable41 | - | €5,250 | €11,209 | €9,637 | ▼ 14.0% |
| Cash at bank and in hand54/58 | €28,291 | €36,913 | €62,726 | €21,503 | ▼ 65.7% |
| Deferred charges and accrued income490/1 | €2,301 | €8,980 | €8,884 | €6,000 | ▼ 32.5% |
| Equity and liabilities | |||||
| Total equity and liabilities10/49 | €37,096 | €53,051 | €83,831 | €103,281 | ▲ 23.2% |
| Equity10/15 | €15,248 | €27,969 | €47,670 | €25,604 | ▼ 46.3% |
| Contributions10/11 | €120 | €120 | €120 | €120 | = |
| Reserves13 | €15,000 | €25,000 | €25,000 | €25,000 | = |
| Distributable reserves133 | €15,000 | €25,000 | €25,000 | €25,000 | = |
| Profit (loss) carried forward14 | €128 | €2,849 | €22,550 | €484 | ▼ 97.9% |
| Amounts payable17/49 | €21,849 | €25,082 | €36,161 | €77,678 | ▲ 115% |
| Amounts payable after more than one year17 | - | - | - | €26,048 | - |
| Financial debts170/4 | - | - | - | €26,048 | - |
| Amounts payable within one year42/48 | €21,849 | €25,082 | €36,161 | €51,630 | ▲ 42.8% |
| Current portion of amounts payable after more than one year42 | - | - | - | €6,739 | - |
| Trade debts44 | €3,369 | €2,524 | €4,895 | €10,219 | ▲ 109% |
| Suppliers440/4 | €3,369 | €2,524 | €4,895 | €10,219 | ▲ 109% |
| Taxes, remuneration and social security45 | €3,460 | €675 | €675 | €827 | ▲ 22.5% |
| Taxes450/3 | €3,460 | €675 | €675 | €827 | ▲ 22.5% |
| Other amounts payable47/48 | €15,020 | €21,883 | €30,591 | €33,845 | ▲ 10.6% |
| Line | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €22,428 | €28,405 | €43,060 | €7,933 | ▼ 81.6% |
| + Depreciation and write-downs630 | €3,247 | €896 | €896 | €12,818 | ▲ 14× |
| Operating cash flow (approximation) | €25,674 | €29,301 | €43,956 | €20,752 | ▼ 52.8% |
| Investment in fixed assets (approximation) | - | €0 | €0 | -€77,947 | - |
| Change in cash | - | €8,621 | €25,814 | -€41,223 | - |
A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.
Filings with the National Bank (4)
Board & ownership
Directors
Directors
1 director, no change since 2022
Astrid PATTYN
Current
Director · since 18-03-2022 · term without a fixed end · listed in the 2025 annual accounts, filed on 22-06-2026
Owners and capital
Owners
Articles of association
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- “Natuurlijke personen of rechtspersonen, al dan niet aandeelhouder, 1”
Articles of association, deed of 22-03-2022 (in Dutch)
Network & group
FORWARD PHYSIO shares no director with another company.
Connections & network
1 current directorThe network starts from the directors of FORWARD PHYSIO. Every other company they run is a node.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.
Timeline
Acts, filings and financial milestones
Deadline for the 2026 accounts:
2026
22-06
micro format · 39 days before the deadline
2025
31-12
Financial
Weakest financial yearnet €7,933 ▼81.6%
The net result drops to €7,933, the lowest from 2022 to 2025.
25-06
micro format · 36 days before the deadline
2024
31-12
Financial
Highest result from 2022 to 2025net €43,060 ▲51.6%
The operating result of €50,804 and the net result of €43,060 are both a record.
15-07
abbreviated format · 16 days before the deadline
2023
17-07
abbreviated format · 14 days before the deadline
2022
22-03
Gazette deed
IncorporationAppointment: Astrid PATTYN (director) · Founder · Founding capital14 points ▸
Gazette deed
Incorporation
Appointment: Astrid PATTYN (director) · Founder · Founding capital14 points ▸
- Incorporation, “Forward Physio” (deed in Dutch)
- Founder, Astrid PATTYN
- Founding capital, €120
- Bank account, “vennootschap in oprichting, BE06 7350 6018 2222” (deed in Dutch)
- Other provision, 15-03-2022
- Other provision, “Wetboek van vennootschappen en verenigingen, bevestiging deponering” (deed in Dutch)
- Capital
- Other provision, “overeenkomstig de wet, uitwerking slot-en overgangsbepalingen” (deed in Dutch)
- Registered office clause, “8800 Roeselare,Kroontjesmolenstraat 1” (deed in Dutch)
- Board rule, 1
- Director appointment, Astrid PATTYN (director)
- Declaration, “verbodsbepaling bestuursmandaat” (deed in Dutch)
- The act holds 2 more points.
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank
History
Company details
Register details
Identity
KBO recordName
FORWARD PHYSIO in Dutch
Enterprise number
0783.593.813
Legal form
Private limited company
Status
Active, normale toestand
Founded
18-03-2022
Entity type
Legal entity
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 22-03-2022 (in Dutch)Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
“Vlaams Gewest, bij enkel besluit bestuursorgaan administratieve zetels,agentschappen,werkhuizen,stapelplaatsen en bijkantoren vestigen in…”
deed of 22-03-2022 (in Dutch)Registered office and establishments
Registered office
Kroontjesmolenstraat 1, 8800 Roeselare, Belgium
Establishment unit
FORWARD PHYSIO, Kroontjesmolenstraat 1, 8800 Roeselare since 18-03-2022 · unit number 2.329.062.5458690501 Human health activities
E-mail
info@forward-physio.be
E-mail
info@nord-health.be
Activities
NACEBEL 202586951
Physiotherapy main activity
85510
Sports and recreation education
85599
Other education
Codes under NACEBEL 2008
86905
Human health activities main activity
85510
Sports and recreation education
85599
Other education
PurposeThe purpose describes the activities the company may carry out under its articles.
deed of 22-03-2022 (in Dutch)
“Het uitoefenen van het beroep van kinesist,osteopaat,logopedist,psychomotorist,psycholoog of ergotherapeut,hetzij alleen,hetzij in…”
18 activities
- Het uitoefenen van het beroep van kinesist,osteopaat,logopedist,psychomotorist,psycholoog of ergotherapeut,hetzij alleen,hetzij in groepsverband.en alle aanverwante activiteiten die verenigbaar zijn met het beroep van kinesist zoals ondermeer het toedienen van acupunctuur,dry-needling,personal training.Voormelde activiteiten kunnen afzonderlijk of samen gesteld worden met andere specialisten.zodat een totaalpakket van diensten kan worden aangeboden.
- Het inrichten van algemene diensten en/of secretariaat in het bijzonder (volledige materiele infrastructuur met alle apparatuur en begeleidende accommodatie) die nuttig of nodig zijn voor de uitoefening van voormelde activiteiten.
- Het creëren van de mogelijkheden om de kinesist-vennoot toe te laten zich verder te bekwamen in voormeld discipline,dit teneinde een kwalitatief hoogstaande praktijkuitoefening mogelijk te maken.
- Het organiseren van en deelnemen aan congressen of voordrachten in dit verband.
- Het ter beschikking stellen van alle nodige middelen voor de uitoefening van de beroepsactiviteit.
- Het aanleggen van reserves teneinde alle nodige apparaten en gebouwen aan te schaffen.
- Zij kan eveneens alle toelevering doen met betrekking tot voormelde activiteiten.
- Het verlenen van diensten en adviezen aan derden.Het verrichten van marktonderzoek;promotie;prospectie;marketing.Assistentie,advies en opleiding op gebied van management,milieu,techniek,automatisatie,informatica,publiciteit,marketing en algemene communicatie onder alle vormen,handel,administratie,financiën,economie.
- Sociaal,fiscaal en juridisch beheer,advies en opleiding.Het optreden als studie-,organisatie- en raadgevend bureau in digitalisatie,informatica en automatisatie.Uitvoeren van alle materieel werk ivm genoemde domeinen;dactylografisch en vertaalbureau.
- Het beheer,het verwerven,de aan- en verkoop,het huren- en verhuren,de commissiehandel en vertegenwoordiging,de instandhouding en valorisatie van roerende goederen,de huurfinanciering,het leasen en in leasing geven van roerende goederen aan derden,alsmede alle handelingen die rechtstreeks of onrechtstreeks met dit voorwerp in verband staan en die van aard zijn de opbrengst van de roerende goederen te bevorderen,zoals het onderhoud,de ontwikkeling,de verfraaiing en de verhuring van deze goederen.
- Het toestaan van leningen en kredietopeningen aan vennootschappen of particulieren onder om het even welke vorm;in dit kader kan zij zich ook borg stellen of haar aval verlenen,in de meest ruime zin,alle handels- en financiële operaties verrichten behalve die welke wettelijk voorbehouden zijn aan depositobanken,houders van deposito's op korte termijn,spaarkassen,hypotheekmaatschappijen en kapitalisatie-ondernemingen.
- Het waarnemen van alle bestuursopdrachten in vennootschappen,het uitoefenen van mandaten en functies in ondernemingen.
- Het aanleggen,het oordeelkundig uitbouwen en beheren van een onroerend vermogen;alle verrichtingen met betrekking tot onroerende goederen en onroerende zakelijke rechten (vruchtgebruik,recht van opstal,erfpacht,…),zoals de huurfinanciering van onroerende goederen aan derden,het aankopen,verkopen,ruilen,bouwen,verbouwen,onderhouden,verhuren,huren,verkavelen,prospecteren en uitbaten van onroerende goederen,het ontwerpen-opvolgen of uitvoeren van projecten,bouwpromotie,en het maken van studies met betrekking tot immobiliën,de aan- en verkoop,commissiehandel en vertegenwoordiging,huur en verhuur van roerende goederen betreffende de inrichting en uitrusting van onroerende goederen,alsmede alle handelingen die rechtstreeks of onrechtstreeks met dit voorwerp in verband staan en die van aard zijn de opbrengst van de onroerende goederen te bevorderen;alsmede zich borg stellen voor het goede verloop van verbintenissen,door derde personen aangegaan,die het genot zouden hebben van voormelde roerende en onroerende goederen.
- Het onderzoek,de ontwikkeling,de vervaardiging of commercialisering van nieuwe producten en technologieën en hun toepassingen;het ontwikkelen,kopen,verkoper,in licentie nemen of geven van octrooien,knowhow en aanverwante immateriële vaste activa.
- De aan- en verkoop,in- en uitvoer,commissiehandel en vertegenwoordiging van om het even welke goederen,in 't kort tussenpersoon in de handel.
- De kleinhandel en groothandel in onder andere volgende waren:voedings- en tabakswaren;verzorgings- en schoonheidsproducten;kruidenierswaren;drogisterijproducten;textielwaren,kleding en schoeisel;artikelen voor meubilering,onderhoud en huishoudelijke uitrusting;luxeartikelen,precisieartikelen,kunstvoorwerpen en fantasieartikelen;papierwaren,boeken,kantoorbehoeften en artikelen voor muziek;artikelen voor sport,visvangst en jacht,in speelgoed en in kinderartikelen;apparaten,elektrische apparaten,voertuigen,diverse artikelen.
- Het aanleggen,het oordeelkundig uitbouwen en beheren van een roerend vermogen;alle verrichtingen met betrekking tot roerende goederen en rechten,van welke aard ook,zoals het verwerven door inschrijving of aankoop,het beheren van aandelen,aandelenopties,obligaties,kasbons,afgeleide producten of andere roerende waarden,van welke vorm ook,uitgegeven door Belgische of buitenlandse emittenten.Het verwerven van participaties,in eender welke vorm,in alle bestaande of op te richten rechtspersonen of ondernemingen;het stimuleren,plannen en coördineren van de ontwikkeling van voormelde rechtspersonen of ondernemingen.
- Alle verrichtingen van commerciële,industriële,onroerende,roerende of financiële aard die rechtstreeks of onrechtstreeks met haar voorwerp verwant of verknocht zijn of de verwezenlijking ervan kunnen bevorderen.
Invoicing and payment
VAT number
BE 0783.593.813
Financial year and general meeting
Accounts at the NBBFinancial year end
31-12
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Third Saturday of June at 19:00
deed of 22-03-2022 (in Dutch)Sites & property
Location
Buildings and parcels at the address
Ground area
664 m²
Building footprint
116 m²
Building volume
710 m³
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 36505B1087/00B000 | Flanders | 664 m² | 1 · 116 m² | 8.5 m · 2 |